Trastuzumab-Associated Dermatomyositis

Am J Ther. 2019 Sep/Oct;26(5):e647-e649. doi: 10.1097/MJT.0000000000000849.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects*
  • Biopsy
  • Breast Neoplasms / drug therapy
  • Dermatomyositis / chemically induced*
  • Dermatomyositis / diagnosis
  • Dermatomyositis / pathology
  • Female
  • Humans
  • Middle Aged
  • Skin / drug effects
  • Skin / pathology
  • Trastuzumab / adverse effects*

Substances

  • Antineoplastic Agents, Immunological
  • Trastuzumab